Automated detection and classification of teardrop cells by a novel RBC module using digital imaging/microscopy
A. Egelé,W. Gelder,J. Riedl
DOI: https://doi.org/10.1111/ijlh.12399
2015-12-01
International Journal of Laboratory Hematology
Abstract:Sir, In a number of diseases, morphological analysis of abnormal red blood cells is of vital importance, contributing to a rapid and correct diagnosis. An example is teardrop cells, which may indicate dyserythropoiesis due to circulation through altered bone marrow sinuses and splenic cords. Teardrop cells in a peripheral blood smear are significant and correlate with several diseases, such as iron deficiency anemia, hemolytic anemia, megaloblastic anemia, and metastatic carcinoma due to bone marrow infiltration and myelofibrosis [1, 2]. Myelofibrosis is characterized by a progressive anemia, pancytopenia, and thrombocytopenia. Typically present are splenomegaly and/or hepatomegaly due to extramedullary erythropoiesis, leukoerythroblastosis caused by the lack of space in the bone marrow due to fibrosis, and the presence of myeloid precursors and teardrop cells in peripheral blood. Nowadays, the grading of abnormal red blood cells is semi-quantitative, usually indicated by a score ranging from 1 to 3 + correlating with the percentage of abnormal cells present. A consistent and standardized international grading system for abnormal red blood cells is still lacking, resulting in scoring percentages that differ per laboratory [2]. In our laboratory, the amount of teardrop cells is indicated with 1 + (which stands for 0.5–2% teardrop cells), 2 + (2–5%), and 3 + (>5%) [3]. To date, no cutoff value is established for the percentage of teardrop cells in a peripheral blood smear, discriminating pathology from nonpathology. If a reliable cutoff value can be determined for this red blood cell abnormality, this could lead to a faster and more accurate detection of myelofibrosis and in distinguishing this disease from benignity. How to realize a good, reliable, and automated screening tool for the detection of morphological red blood cell abnormalities (e.g., teardrop cells)? Automated morphological analysis and classification of leukocytes with the use of digital microscopy is nowadays a routine procedure in a large number of laboratories globally [4]. Recently, a novel software tool has been developed to detect and classify morphological abnormalities of red blood cells (advanced RBC application). The advanced RBC application (CellaVision) is basically a RBC cell-locating device. The system identifies and segments red blood cells. Each red blood cell is then characterized for size, shape, color, and inclusion. The characterizations for shape, color, and inclusion are performed by an artificial neural network. This network is trained by a number of highly qualified experts, and the network uses 80 features computed for each RBC image. Examples of used features are size, roundness, distribution of notches around the border, size, and shape of inner pallor. The user can verify or change any suggested morphology. The results are represented as a percentage value and a grading which is based on a conversion table defined by the user in the settings file. We evaluated and validated this module, using a cohort of patient samples and healthy controls, and compared preand postclassification results. Preclassification was performed by the RBC classification module without manual intervention (Figure 1), and the postclassification was performed by a morphological expert. Subsequently, statistical analysis was performed to determine the accuracy and correlation. Classification analysis of teardrop cells was performed on 46 peripheral blood smears from patients in which teardrop cells were present and a cohort of normal blood smears (n = 10). The slides were prepared using the SP10 (slide maker/stainer; Sysmex, Etten-Leur, the Netherlands) from venous blood samples collected in EDTA tubes and stained according to the May–Gr€ unwald– Giemsa stain. Of these 46 patients, fifteen were diagnosed with myelofibrosis, confirmed by bone marrow analysis. Myelofibrosis evolved from polycythemia vera (PV) in four patients and from essential thrombocythemia (ET) in five patients. Three patients were diagnosed with primary myelofibrosis (PMF) and three with idiopathic myelofibrosis (IMF). Among the other 31 samples, six were diagnosed with a myelodysplastic syndrome (MDS), four with chronic lymphocytic leukemia (CLL), three with an iron deficiency, one with ET, two with PV,